Skip to main content
. 2015 Sep 15;113(8):1206–1215. doi: 10.1038/bjc.2015.327

Table 1. Patient characteristics.

  mKRAS mEGFR WT KRAS/EGFR P value
Total N 265 (31.5) 103 (12.2) 473 (56.3)  
Male 174 (65.7) 29 (28.4) 318 (67.2) <0.0001
Mean age (y) 63.26±10.07 63.67±14.23 63.39±11.65 0.95
pT       0.002
 1 59 (22.3) 22 (21.4) 132 (27.9)  
 2 129 (48.7) 49 (47.6) 173 (36.6)  
 3 66 (24.9) 30 (29.1) 125 (26.4)  
 4 11 (4.2) 2 (1.9) 43 (9.1)  
pN+ 216 (81.5) 32 (31.1) 177 (37.4) <0.0001
pN       <0.0001
 pN0 49 (18.5) 71 (68.9) 296 (62.6)  
 pN1 156 (58.9) 15 (14.6) 84 (17.8)  
 pN2 60 (22.6) 17 (16.5) 93 (19.7)  
Skip N 9 (15) 9 (60) 0 <0.0001
Microscopic N 20 (9.3) 17 (53.1) 0 <0.0001
Number of N2 stations       0.004
 1 37 (61.7) 14 (82.4) 78 (84.8)  
 2 23 (38.3) 3 (17.6) 14 (15.2)  
Smoking       <0.0001
 Never 36 (13.6) 91 (88.3) 43 (9.1)  
 Past 101 (38.1) 6 (5.8) 210 (44.4)  
 Current 128 (48.3) 6 (5.8) 220 (46.5)  
R0 resection 263 (99.2) 101 (98.1) 464 (98.1) 0.45
Angioinvasion 155 (58.5) 17 (16.5) 157 (33.2) <0.0001
Neo-adjuvant treatment 97 (36.6) 34 (33) 198 (41.9) 0.15
Type of neo-adjuvant treatment       0.15
 Chemo. 74 (76.3) 23 (67.6) 160 (80.8)  
 RT chemo. 23 (23.7) 11 (32.4) 38 (19.2)  
Type of resection       0.13
 Lobectomy 243 (91.7) 9 (88.3) 403 (85.2)  
 Bi-lobectomy 12 (4.5) 4 (3.9) 32 (6.8)  
 Pneumonectomy 1 (0.4) 2 (1.9) 14 (3)  
 Segmentectomy 9 (3.4) 6 (5.8) 24 (5.1)  
Adjuvant treatment 217 (81.9) 34 (33) 183 (38.7) <0.0001
Type of adjuvant treatment       <0.0001
 RT 1 (0.5) 2 (5.9) 6 (3.3)  
 Chemo. 194 (89.4) 32 (94.1) 149 (81.4)  
 RT chemo. 22 (10.1) 0 28 (15.3)  
CCI       0.45
 0 22 (8.3) 13 (12.6) 54 (11.4)  
 1 99 (37.4) 46 (44.7) 171 (36.2)  
 2 72 (27.2) 21 (20.4) 120 (25.4)  
 3 72 (27.2) 23 (22.3) 128 (27.1)  

Abbreviations: chemo.=chemotherapy; CCI=Charlson comorbidity index; RT=radiation therapy; y=years.

Data are given as n (%).